glycogen synthase kinase 3 beta inhibitors (Fudan university/Fudan University Shanghai Medical College/Shanghai Institute of Materia Medica of the Chinese Academy of Sciences)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameglycogen synthase kinase 3 beta inhibitors (Fudan university/Fudan University Shanghai Medical College/Shanghai Institute of Materia Medica of the Chinese Academy of Sciences)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlycogen synthase kinase-3 beta inhibitors
TargetsGlycogen synthase kinase-3 beta
Therapy Area/IndicationsInsulin ResistanceDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesFudan University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsInsulin ResistanceDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A